최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기AAPS PharmSciTech, v.13 no.1, 2012년, pp.276 - 283
Li, Bei , Ge, Zhi-Qiang
초록이 없습니다.
J Cosmet Dermatol DH Mcdaniel 4 167 2005 10.1111/j.1473-2165.2005.00305.x Mcdaniel DH, Neudecker BA, Dinardo JC, Lewis JA, Maibach H. Clinical efficacy assessment in photodamage skin of 0.5% and 1.0% idebenone. J Cosmet Dermatol. 2005;4:167-73.
Dermatol Ther P Farris 20 322 2007 10.1111/j.1529-8019.2007.00146.x Farris P. Idebenone, green tea, and Coffeeberry® extract: new and innovative antioxidants. Dermatol Ther. 2007;20:322-9.
J Cosmet Dermatol DH McDaniel 4 10 2005 10.1111/j.1473-2165.2005.00152.x McDaniel DH, Neudecker BA, DiNardo JC, Lewis JA, Maibach HI. Idebenone: a new antioxidant-Part I. Relative assessment of oxidative stress protection capacity compared to commonly known antioxidants. J Cosmet Dermatol. 2005;4:10-7.
Nanomedicine CM Amorim 6 745 2010 10.1016/j.nano.2010.06.006 Amorim CM, Couto AG, Netz DJA, de Freitas RA, Bresolin TMB. Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosan. Nanomedicine. 2010;6:745-52.
Pharm Res M Palumbo 19 71 2002 10.1023/A:1013659516878 Palumbo M, Russo A, Cardile V, Renis M, Paolino D, Puglis G, Fresta M. Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts. Pharm Res. 2002;19:71-8.
Adv Drug Deliv Rev M Amidi 62 59 2010 10.1016/j.addr.2009.11.009 Amidi M, Mastrobattista E, Jiskoot W, Hennink WH. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev. 2010;62:59-82.
Adv Drug Deliv Rev RH Muller 59 522 2007 10.1016/j.addr.2007.04.012 Muller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522-30.
Eur J Pharm Biopharm WM Obeidat 76 56 2010 10.1016/j.ejpb.2010.05.001 Obeidat WM, Schwabe K, Muller RH, Keck CM. Preservation of nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2010;76:56-67.
Adv Drug Deliv Rev W Mehnert 47 165 2001 10.1016/S0169-409X(01)00105-3 Mehnert W, Mader K. Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165-96.
Eur J Pharm Biopharm CC Chen 74 474 2010 10.1016/j.ejpb.2009.12.008 Chen CC, Tsai TH, Huang ZR, Fang JY. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 2010;74:474-82.
J Neurosci Meth R Artuch 115 63 2002 10.1016/S0165-0270(01)00533-7 Artuch R, Colome C, Vilaseca MA, Aracil A, Pineda M. Monitoring of idebenone treatment in patients with Friedreich’s ataxia by high-pressure liquid chromatography with electrochemical detection. J Neurosci Meth. 2002;115:63-6.
Eur J Pharm Biopharm JY Fang 70 633 2008 10.1016/j.ejpb.2008.05.008 Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70:633-40.
Int J Pharm A Gillet 411 223 2011 10.1016/j.ijpharm.2011.03.049 Gillet A, Compre P, Lecomte F, Hubert P, Ducat E, Evrard B, et al. Liposome surface charge influence on skin penetration behaviour. Int J Pharm. 2011;411:223-31.
Int J Pharm VB Junyaprasert 377 207 2009 10.1016/j.ijpharm.2009.05.020 Junyaprasert VB, Teeranachaideekul V, Souto EB, Boonme P, Muller RH. Q10-loaded NLC versus nanoemulsions: stability, rheology and in vitro skin permeation. Int J Pharm. 2009;377:207-14.
Pharm Res D Driscoll 23 1959 2006 10.1007/s11095-006-9092-4 Driscoll D. Lipid injectable emulsions: pharmacopeial and safety issues. Pharm Res. 2006;23:1959-69.
Adv Drug Deliv Rev RH Muller 54 131 2002 10.1016/S0169-409X(02)00118-7 Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:131-55.
Int J Pharm S Peltola 254 99 2003 10.1016/S0378-5173(02)00632-4 Peltola S, Saarinen-Savolainen P. Microemulsions for topical delivery of estradiol. Int J Pharm. 2003;254:99-107.
Int J Pharm C Freitas 168 221 1998 10.1016/S0378-5173(98)00092-1 Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm. 1998;168:221-9.
AAPS PharmSciTech P Pathak 10 985 2009 10.1208/s12249-009-9287-1 Pathak P, Nagarsenker M. Formulation and evaluation of lidocaine lipid nanosystems for demal delivery. AAPS PharmSciTech. 2009;10:985-92.
J Pharmaceut Biomed R Tursilli 40 910 2006 10.1016/j.jpba.2005.08.025 Tursilli R, Casolari A, Iannuccelli V, Scalia S. Enhancement of melatonin photostability by encapsulation in lipospheres. J Pharmaceut Biomed. 2006;40:910-4.
Chem Res Toxicol A Mordente 11 54 1998 10.1021/tx970136j Mordente A, Martorana GE, Minotti G, Giardina B. Antioxidant properties of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4- benzoquinone (Idebenone). Chem Res Toxicol. 1998;11:54-63.
J Control Release R Alvarez-Roman 99 53 2004 10.1016/j.jconrel.2004.06.015 Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99:53-62.
Nano Lett JG Rouse 7 155 2007 10.1021/nl062464m Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro-Riviere NA. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007;7:155-60.
Ind J Pharmacol P Singh 32 269 2000 Singh P, Sihorkar V, Jaitely V, Kanaujia P, Vyas SP. Pilosebaceous unit: anatomical considerations and drug delivery opportunities. Ind J Pharmacol. 2000;32:269-81.
Eur J Pharm Biopharm J Lademann 77 465 2011 10.1016/j.ejpb.2010.10.015 Lademann J, Richter H, Schanzer S, Knorr F, Meinke M, Sterry W, et al. Penetration and storage of particles in human skin: perspectives and safety aspects. Eur J Pharm Biopharm. 2011;77:465-8.
J Invest Dermatol R Toll 123 168 2004 10.1111/j.0022-202X.2004.22717.x Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol. 2004;123:168-76.
Eur J Pharm Biopharm J Lademann 66 159 2007 10.1016/j.ejpb.2006.10.019 Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66:159-64.
Int J Pharm A Nokhodchi 250 359 2003 10.1016/S0378-5173(02)00554-9 Nokhodchi A, Shokri J, Dashbolaghi A, Hassan-Zadeh D, Ghafourian T, Barzegar-Jalali M. The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int J Pharm. 2003;250:359-69.
Exp Dermatol JD Bos 9 165 2000 10.1034/j.1600-0625.2000.009003165.x Bos JD, Meinardi MMHM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9:165-9.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.